L'hôpital d'Estaing ou CHU Estaing est un hôpital situé à Clermont-Ferrand, dans le Puy-de-Dôme. Il fait partie du CHU de Clermont-Ferrand.

During the past decade, CHU Estaing - Hématologie Clinique Adulte conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Estaing - Hématologie Clinique Adulte" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "CHU Estaing - Hématologie Clinique Adulte" are "Acute Myeloid Leukemia" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Bruton Tyrosine Kinase Inhibitor" (1 trials) and "CLL, Refractory" (1 trials). Many other conditions were trialed in "CHU Estaing - Hématologie Clinique Adulte" in a lesser frequency.

Most popular intervention types in "CHU Estaing - Hématologie Clinique Adulte" are "Drug" (12 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Obinutuzumab" (3 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials) and "Chlorambucil" (2 trials). Other intervention names were less common.

The vast majority of trials in "CHU Estaing - Hématologie Clinique Adulte" are 14 trials for "All" genders.

Currently, there are NaN active trials in "CHU Estaing - Hématologie Clinique Adulte". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in CHU Estaing - Hématologie Clinique Adulte, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Estaing - Hématologie Clinique Adulte, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".